Onconova Therapeutics (ONTX) Tops Q3 EPS by 6c

Onconova Therapeutics (NASDAQ: ONTX) reported Q3 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $60 thousand versus the consensus estimate of $69.25 thousand.

For earnings history and earnings-related data on Onconova Therapeutics (ONTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15